01 October 2007
Satisfaction with breast cancer screening and future screening participation
Alexander Stojadinovic, Leonard R Henry, George E Peoples, Elizabeth A Mittendorf, Sarah Lenington, Aviram Nissan, Craig D ShriverMed Sci Monit 2007; 13(10): CR422-429 :: ID: 502356
Abstract
Background: To measure satisfaction with an investigational breast cancer risk screening technique [electrical impedance scanning (EIS)] and to investigate the relationship between satisfaction and willingness to return for follow-up examination one year later.
Material/Methods: 2727 women volunteers (age 18–45 years, military healthcare beneficiaries) underwent an EIS exam [reported as "negative" (average risk) or "positive" (high risk)]; then they filled out a questionnaire assessing satisfaction with the procedure. One year later, women were invited for follow-up screening.
Results: Satisfaction score was significantly related to EIS exam result (higher for women with negative exams), importance assigned to breast cancer screening, and family history of breast cancer. However, satisfaction was not related to scheduling a visit the following year for a follow-up examination. The only satisfaction component predicting return was satisfaction with exam reporting for participants with positive exam results. Return was related positively to age and race/ethnicity; older women and Hispanic women were more likely, while African American women were less likely, to return for follow-up.
Conclusions: Factors affecting breast cancer screening participation among younger women are diverse and complex. Further study and delineation of such factors is necessary to understand how best to tailor breast cancer education programs in young women.
Keywords: Adolescent, Breast Neoplasms - diagnosis, Follow-Up Studies, Health Surveys, Mass Screening, Patient Satisfaction, Questionnaires
577 2
Editorial
01 May 2023 : Editorial
Editorial: Twenty Years On from Sequencing the Human Genome, Personalized/Precision Oncology Prepares to Meet the Challenges of Checkpoint Inhibitor TherapyDOI: 10.12659/MSM.940911
Med Sci Monit 2023; 29:e940911
In Press
31 May 2023 : Review article
Prevalence, Diagnosis, and Management of Eclampsia and the Need for Improved Maternal Care: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.939919
30 May 2023 : Clinical Research
A Case-Control Study of Cognitive Function in Patients with End-Stage Renal Disease Before and After Hemodi...Med Sci Monit In Press; DOI: 10.12659/MSM.940409
30 May 2023 : Review article
A Review of the Role of the Zebrafish (Danio reiro) in Preclinical and Clinical Models of Biomarker Identif...Med Sci Monit In Press; DOI: 10.12659/MSM.940550
30 May 2023 : Database Analysis
The COVID-19 Crisis and the Incidence of Alcohol-Related Deaths in PolandMed Sci Monit In Press; DOI: 10.12659/MSM.940904
Most Viewed Current Articles
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952